Your browser doesn't support javascript.
loading
Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.
Suarez, Oscar; Perez, María; Garzon, Martin; Daza, Rodrigo; Hernandez, Geovanny; Salinas, Carolina; Ceballos, Jorge; de Leon, Enrique P; Mugnier, Jacqueline; Beltrán, Oscar; Varón, Adriana.
Afiliação
  • Suarez O; Gastroenterology Fellowship, Universidad del Rosario, School of Medicine and Health Sciences, Bogotá, Colombia.
  • Perez M; Department of Medicine, Division of Internal Medicine, Universidad del Rosario, Bogotá D.C., Cundinamarca, Colombia.
  • Garzon M; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Daza R; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Hernandez G; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Salinas C; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Ceballos J; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • de Leon EP; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Mugnier J; Department of Medicine, Division of Pathology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Beltrán O; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
  • Varón A; Department of Medicine, Division of Gastroenterology and Hepatology, Fundación Cardio Infantil, Bogotá D.C., Cundinamarca, Colombia.
Case Reports Hepatol ; 2018: 7521986, 2018.
Article em En | MEDLINE | ID: mdl-30631612
ABSTRACT
Fibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma in young patients, and its lack of association with underlying liver disease. The clinical presentation is unspecific, with symptoms ranging from abdominal pain, malaise, and weight loss to atypical manifestation which include hyperammonemic encephalopathy. We present the case of a 33-year-old woman with no prior medical history who presented with a coma and a diagnosis of inoperable fibrolamellar hepatocarcinoma requiring a cadaver donor transplant. While she was on the waiting list, she received hemofiltration and ammonium benzoate treatment, with progressive improvement in her state of consciousness.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Case Reports Hepatol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Colômbia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Case Reports Hepatol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Colômbia